000 01571 a2200505 4500
005 20250513135548.0
264 0 _c19980326
008 199803s 0 0 eng d
022 _a0250-7005
040 _aNLM
_beng
_cNLM
100 1 _aAltuntas, T G
245 0 0 _aComutagenesis-IV in vitro metabolism of the comutagen 2-amino-3-methylpyridine: species differences and metabolic interaction with norharman.
_h[electronic resource]
260 _bAnticancer research
_c
300 _a4479-82 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAminopyridines
_xpharmacokinetics
650 0 4 _aAnimals
650 0 4 _aAroclors
_xpharmacology
650 0 4 _aBiotransformation
650 0 4 _aCallithrix
650 0 4 _aCarbolines
650 0 4 _aCarcinogens
_xpharmacology
650 0 4 _aChlorodiphenyl (54% Chlorine)
650 0 4 _aCricetinae
650 0 4 _aCytosol
_xmetabolism
650 0 4 _aDogs
650 0 4 _aGuinea Pigs
650 0 4 _aHarmine
_xanalogs & derivatives
650 0 4 _aHydroxylation
650 0 4 _aLiver
_xdrug effects
650 0 4 _aMale
650 0 4 _aMesocricetus
650 0 4 _aMice
650 0 4 _aMice, Inbred Strains
650 0 4 _aMicrosomes, Liver
_xdrug effects
650 0 4 _aMutagens
_xpharmacokinetics
650 0 4 _aOxidation-Reduction
650 0 4 _aPicolines
_xpharmacokinetics
650 0 4 _aRabbits
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aSpecies Specificity
700 1 _aGorrod, J W
773 0 _tAnticancer research
_gvol. 17
_gno. 6D
_gp. 4479-82
999 _c9462664
_d9462664